Stryker (NYSE:SYK – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” ...

Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for ...

Stryker ( (SYK) ) has provided an announcement. Stryker Corporation has announced a definitive agreement to acquire Inari ...

JMP Securities reissued their market perform rating on shares of Stryker (NYSE:SYK – Free Report) in a research note issued ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired ...

Highlights,Stryker beats earnings expectations with strong quarterly results.,Institutional investors show growing confidence by increasing their stakes.,Stryker continues to lead in orthopaedics and ...

Stryker (SYK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Wood from Morgan ...

The deal for Inari bolsters Stryker’s efforts to treat a condition called venous thromboembolism where a blood clot forms in ...

Stryker (SYK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Caitlin Cronin from ...

Stryker shares are currently trading up by 0.25%, with a current price of $362.34 as of Tuesday morning. This brings the total value of Boehnlein's 2,000 shares to $479,659.

Portage, Michigan-based Stryker Corporation (SYK) offers innovative products and services in MedSurg, Neurotechnology, ...